Product code MXZ— Hematology

BIOGENEX MONOCLONAL ANTI-PROGESTERONE RECEPTOR

Classification name
Immunohistochemistry Assay, Antibody, Progesterone Receptor
Device class
Class 2
Regulation
21 CFR 864.1860
Advisory panel
Hematology
Total cleared
13
First cleared
Most recent

Market context for product code MXZ

FDA has cleared 13 devices under product code MXZ between 1999 and 2020, filed by 11 applicant companies. No FDA device recalls reference this product code. Class II devices are moderate-risk and subject to general and special controls; most reach market through 510(k) clearance by demonstrating substantial equivalence to a predicate device.

Clearances per year

Top applicants under product code MXZ

Recent clearances under product code MXZ

Data sourced from openFDA. This site is unofficial and independent of the FDA.